New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology
Articolo
Data di Pubblicazione:
2019
Citazione:
New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology / A. Bellasi, M. Cozzolino, F. Malberti, G. Cancarini, C. Esposito, C.M. Guastoni, P. Ondei, G. Pontoriero, U. Teatini, G. Vezzoli, M. Pasquali, P. Messa, F. Locatelli. - In: JN. JOURNAL OF NEPHROLOGY. - ISSN 1121-8428. - (2019). [Epub ahead of print] [10.1007/s40620-019-00677-0]
Abstract:
Bone mineral abnormalities (defined as Chronic Kidney Disease Mineral Bone Disorder; CKD-MBD) are prevalent and associated with a substantial risk burden and poor prognosis in CKD population. Several lines of evidence support the notion that a large proportion of patients receiving maintenance dialysis experience a suboptimal biochemical control of CKD-MBD. Although no study has ever demonstrated conclusively that CKD-MBD control is associated with improved survival, an expanding therapeutic armamentarium is available to correct bone mineral abnormalities. In this position paper of Lombardy Nephrologists, a summary of the state of art of CKD-MBD as well as a summary of the unmet clinical needs will be provided. Furthermore, this position paper will focus on the potential and drawbacks of a new injectable calcimimetic, etelcalcetide, a drug available in Italy since few months ago.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
CKD-MBD; Cinacalcet; Etelcalcetide; PTH; Secondary hyperparathyroidism;
Elenco autori:
A. Bellasi, M. Cozzolino, F. Malberti, G. Cancarini, C. Esposito, C.M. Guastoni, P. Ondei, G. Pontoriero, U. Teatini, G. Vezzoli, M. Pasquali, P. Messa, F. Locatelli
Link alla scheda completa: